Literature DB >> 11973155

IFN-gamma and NO in mycobacterial disease: new jobs for old hands.

Andrea M Cooper1, Linda B Adams, Dyana K Dalton, Rui Appelberg, Stefan Ehlers.   

Abstract

Granulomatous disease following exposure to Mycobacterium tuberculosis, Mycobacterium leprae or Mycobacterium avium is correlated with strong inflammatory and protective responses. The mouse model of mycobacterial infection provides an excellent tool with which to examine the inter-relationship between protective cell-mediated immunity and tissue-damaging hypersensitivity. It is well established that T cells and interferon (IFN)-gamma are necessary components of anti-bacterial protection. We propose that IFN-gamma also modulates the local cellular response by downregulating lymphocyte activation and by driving T cells into apoptosis, and that the events that limit excessive inflammation are largely mediated by IFN-gamma-induced nitric oxide (NO). In several murine models of mycobacterial infection, the absence of IFN-gamma and/or NO results in dysregulated granuloma formation and increased lymphocytic responses, which, in the case of M. avium infection, even leads to reduced bacterial growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973155     DOI: 10.1016/s0966-842x(02)02344-2

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  35 in total

1.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 2.  Mycobacteria-induced suppression of autoimmunity in the central nervous system.

Authors:  JangEun Lee; Matyas Sandor; Erika Heninger; Zsuzsanna Fabry
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-24       Impact factor: 4.147

3.  Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection.

Authors:  Manuela Flórido; John E Pearl; Alejandra Solache; Margarida Borges; Laura Haynes; Andrea M Cooper; Rui Appelberg
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.

Authors:  Margarida Borges; Palmira Barreira-Silva; Manuela Flórido; Michael B Jordan; Margarida Correia-Neves; Rui Appelberg
Journal:  J Immunol       Date:  2012-08-24       Impact factor: 5.422

Review 5.  Mouse model of tuberculosis.

Authors:  Andrea M Cooper
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-25       Impact factor: 6.915

Review 6.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

7.  Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Christopher S Eickhoff; Daniel F Hoft; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

8.  Immunology of tuberculosis.

Authors:  Qing Zhang; Isamu Sugawara
Journal:  World J Exp Med       Date:  2012-08-20

9.  Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Authors:  Vanitha S Raman; Joanne O'Donnell; H Remy Bailor; Wakako Goto; Ramanuj Lahiri; Thomas P Gillis; Steven G Reed; Malcolm S Duthie
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

10.  Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture.

Authors:  Jaiyanth Daniel; Chirajyoti Deb; Vinod S Dubey; Tatiana D Sirakova; Bassam Abomoelak; Hector R Morbidoni; Pappachan E Kolattukudy
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.